Profile data is unavailable for this security.
About the company
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated turnkey solutions, Biomedical and Investment holding. Its Integrated turnkey solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanroom and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services and the operating of medical laboratories and development of regenerative wellness products. The Company provides laboratory services including storage and handling stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn Bhd, Supergenics Life Science Sdn Bhd, Supergenics Therapeutic Sdn Bhd, Supergenics Bio Agro Sdn Bhd, Supergenics Stembank Sdn Bhd and others.
- Revenue in MYR (TTM)10.24m
- Net income in MYR176.86k
- Incorporated2016
- Employees9.00
- LocationSupergenics BhdSELANGOR DARUL EHSAN 47650MalaysiaMYS
- Phone+60 351150437
- Websitehttps://www.supergenic.com.my/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chimeric Therapeutics Ltd | 0.00 | -34.78m | 51.19m | -- | -- | 0.9948 | -- | -- | -0.027 | -0.027 | 0.00 | 0.0191 | 0.00 | -- | -- | -- | -45.96 | -- | -69.36 | -- | -- | -- | -- | -- | -- | -10.01 | 0.1596 | -- | -- | -- | -60.40 | -- | -- | -- |
| China Health Group Inc | 13.76m | -37.39m | 51.22m | 42.00 | -- | 0.9401 | -- | 3.72 | -0.0628 | -0.0628 | 0.0231 | 0.0915 | 0.1438 | -- | 0.246 | 547,598.90 | -39.07 | 6.84 | -51.26 | 9.52 | 38.33 | 74.98 | -271.70 | 19.19 | -- | -- | 0.00 | 0.00 | 63.67 | -18.51 | -267.82 | -- | 30.37 | -- |
| Amplia Therapeutics Ltd | 13.65m | -13.85m | 52.28m | 1.00 | -- | 1.08 | -- | 3.83 | -0.0226 | -0.0226 | 0.0222 | 0.0572 | 0.2647 | -- | 2.05 | -- | -26.86 | -25.13 | -32.90 | -27.42 | -- | -- | -101.48 | -206.74 | -- | -- | 0.122 | -- | 286.42 | 144.81 | 27.86 | -- | -6.91 | -- |
| PhoenixBio Co Ltd | 52.08m | 800.93k | 63.32m | 70.00 | 144.65 | 1.15 | 40.41 | 1.22 | 3.55 | 3.55 | 409.59 | 446.27 | 0.5983 | 1.28 | 6.80 | 24,504,590.00 | 0.9201 | -4.04 | 1.31 | -5.28 | 69.67 | 65.88 | 1.54 | -6.97 | 3.99 | -- | 0.2871 | -- | -19.24 | 6.91 | -94.65 | -- | -9.96 | -- |
| BPH Energy Ltd | 1.06m | 2.75m | 65.29m | 2.00k | 18.88 | 0.9128 | -- | 61.42 | 0.001 | 0.001 | 0.0004 | 0.0203 | 0.0177 | -- | 5.97 | -- | 4.58 | -6.89 | 4.78 | -7.72 | 56.39 | -- | 258.50 | -357.76 | -- | -- | 0.0043 | -- | 96.54 | 5.21 | 179.13 | -- | -- | -- |
| Alterity Therapeutics Ltd | 379.67k | -37.77m | 65.44m | 11.00 | -- | 0.6361 | -- | 172.37 | -0.005 | -0.005 | 0.00005 | 0.0063 | 0.0044 | -- | 1.52 | 11,223.64 | -44.20 | -53.02 | -53.57 | -61.96 | -- | -- | -9,947.97 | -40,995.62 | -- | -- | 0.0143 | -- | 557.60 | -39.40 | -7.47 | -- | -34.88 | -- |
| Noxopharm Ltd | 12.00m | -37.29m | 66.50m | 1.00k | -- | 3.29 | -- | 5.54 | -0.0415 | -0.0415 | 0.0134 | 0.0225 | 0.2684 | -- | 1.64 | 3,901.84 | -83.43 | -50.96 | -94.78 | -62.98 | -- | -- | -310.82 | -191.70 | -- | -1.47 | 0.00 | -- | 11.32 | 44.02 | 19.34 | -- | -- | -- |
| Supergenics Bhd | 10.24m | 176.86k | 69.41m | 9.00 | 320.86 | 7.43 | 60.49 | 6.78 | 0.0019 | 0.0019 | 0.1086 | 0.0807 | 0.5869 | 15.72 | 1.22 | -- | 0.8456 | -1.02 | 1.37 | -1.57 | 45.41 | 33.88 | 1.44 | -1.42 | 1.86 | 2.70 | 0.3717 | -- | -4.47 | 8.99 | -48.85 | -34.94 | 143.02 | -- |
| Tryptamine Therapeutics Ltd | 3.71m | -13.28m | 70.33m | -- | -- | 3.40 | -- | 18.94 | -0.0162 | -0.0162 | 0.0039 | 0.0062 | 0.2368 | -- | -- | -- | -84.69 | -- | -120.26 | -- | -- | -- | -357.70 | -- | -- | -21.62 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| LBT Innovations Limited | 6.16m | -65.73m | 77.03m | 17.00 | -- | 7.90 | -- | 12.50 | -0.0428 | -0.0428 | 0.0038 | 0.002 | 0.1087 | 0.0819 | 2.25 | 117,882.40 | -115.89 | -28.85 | -131.86 | -30.99 | 94.76 | -- | -1,066.62 | -441.76 | 3.30 | -6.85 | 0.5633 | -- | -5.29 | -18.45 | -239.17 | -- | -34.63 | -- |
| Invion Ltd | 13.71m | -4.61m | 81.24m | 8.00 | -- | 1.44 | -- | 5.92 | -0.0002 | -0.0002 | 0.0007 | 0.0028 | 0.2345 | -- | 3.20 | -- | -7.88 | -16.93 | -8.12 | -18.13 | -- | -- | -33.60 | -51.63 | -- | -- | 0.00 | -- | 25.72 | 41.18 | 27.95 | -- | -- | -- |
| Cannasouth Ltd | 2.65m | -24.41m | 89.74m | -- | -- | 0.6699 | -- | 33.89 | -0.0352 | -0.0353 | 0.0044 | 0.1463 | 0.026 | 1.67 | 3.33 | -- | -23.95 | -25.58 | -26.28 | -27.74 | -127.65 | -- | -921.78 | -1,678.99 | 1.06 | -80.14 | 0.0913 | -- | 579.62 | -- | -11.15 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Phillip Capital Management Sdn. Bhd.as of 31 Dec 2023 | 750.00k | 0.65% |
